Proposed variation to registration of Draxxin Injectable Solution containing the approved active constituent tulathromycin

This consultation closed on 16 July 2013.
Consultation period: 
18 June 2013 to 16 July 2013

The APVMA is considering an application to vary the use of the existing registered product Draxxin Injectable Solution containing the approved active constituent tulathromycin (APVMA Product number 60018).

We invite written comment from 18 June 2013 to 16 July 2013 on the trade implications of this registration proposal.

The APVMA is able to consider comments relating to the legislative grounds for the assessment, which are the trade implications of the use of the product. The Trade Advice Notice provides a summary of the APVMA's residue and trade assessment.

Download the Trade Advice Notice on tulathromycin in the Product Draxxin Injectable Solution.

Email your written submissions to vetmedicines@apvma.gov.au. We prefer emailed submissions. However, hardcopy submissions (or files on digital media) can be sent to:

Contact Officer, Veterinary Medicines
Veterinary Medicines Program
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
KINGSTON ACT 2604

For enquiries, please call: +61 2 6210 4789

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.